Richard Bergenstal MD

Dr. Richard M. Bergenstal is an endocrinologist and Executive Director of the International Diabetes Center, HealthPartners Institute. He is a Clinical Professor in the Department of Medicine at the University of Minnesota, Minneapolis, MN, USA, and served as President, Science & Medicine of the American Diabetes Association in 2010. In 2007, Dr Bergenstal was named the ADA’s Outstanding Clinician of the Year. He received his MD and endocrine training from the University of Chicago, IL, where he was an Assistant Professor of Medicine before joining the International Diabetes Center in 1983.

Dr. Bergenstal’s clinical research focuses on optimising glucose management and reducing diabetes complications, and he has served as Principal Investigator (PI) for multiple National Institutes of Health (NIH) trials, including DCCT/EDIC, ACCORD, and GRADE. Dr Bergenstal also focuses on clinical trials, leading the approval and effective use of advanced diabetes technology, including continuous glucose monitoring (CGM) and automated insulin delivery systems, being PI on NIH grants studying an insulin dose advisor system and the next-generation automated insulin delivery systems, and Co-PI on a Patient-Centered Outcomes Research Institute (PCORI) grant evaluating CGM versus blood glucose monitoring to guide insulin therapy in the primary care settings.

Dr. Bergenstal has worked to standardise CGM metrics and the data display in the Ambulatory Glucose Profile (AGP) report, which is now being integrated directly into the electronic health record, and the data output is organised to help guide and personalise diabetes management. He teaches nationally and internationally on the importance of patient‐centred team care, has been listed in Best Doctors in America since it began in 1992, and has published over 400 peer-reviewed scientific articles.